Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK Activation

Enterochromaffin-like (ECL) cells in the stomach express gastrin/cholecystokinin 2 receptor CCK2R and are known to expand under hypergastrinemia, but whether this results from expansion of existing ECL cells or increased production from progenitors has not been clarified. We used mice with green flu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cellular and molecular gastroenterology and hepatology 2020-01, Vol.10 (2), p.434-449.e1
Hauptverfasser: Sheng, Weiwei, Malagola, Ermanno, Nienhüser, Henrik, Zhang, Zhengyu, Kim, Woosook, Zamechek, Leah, Sepulveda, Antonia, Hata, Masahiro, Hayakawa, Yoku, Zhao, Chun-Mei, Chen, Duan, Wang, Timothy C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 449.e1
container_issue 2
container_start_page 434
container_title Cellular and molecular gastroenterology and hepatology
container_volume 10
creator Sheng, Weiwei
Malagola, Ermanno
Nienhüser, Henrik
Zhang, Zhengyu
Kim, Woosook
Zamechek, Leah
Sepulveda, Antonia
Hata, Masahiro
Hayakawa, Yoku
Zhao, Chun-Mei
Chen, Duan
Wang, Timothy C.
description Enterochromaffin-like (ECL) cells in the stomach express gastrin/cholecystokinin 2 receptor CCK2R and are known to expand under hypergastrinemia, but whether this results from expansion of existing ECL cells or increased production from progenitors has not been clarified. We used mice with green fluorescent protein fluorescent reporter expression in ECL cells (histidine decarboxylase [Hdc]-green fluorescent protein), as well as Cck2r- and Hdc-driven Tamoxifen inducible recombinase Cre (Cck2r-CreERT2, Hdc-CreERT2) mice combined with Rosa26Sor-tdTomato (R26-tdTomato) mice, and studied their expression and cell fate in the gastric corpus by using models of hypergastrinemia (gastrin infusion, omeprazole treatment). Hdc-GFP marked the majority of ECL cells, located in the lower third of the gastric glands. Hypergastrinemia led to expansion of ECL cells that was not restricted to the gland base, and promoted cellular proliferation (Ki67) in the gastric isthmus but not in basal ECL cells. Cck2r-CreERT2 mice marked most ECL cells, as well as scattered cell types located higher up in the glands, whose number was increased during hypergastrinemia. Cck2r-CreERT2+ isthmus progenitors, but not Hdc+ mature ECL cells, were the source of ECL cell hyperplasia during hypergastrinemia and could grow as 3-dimensional spheroids in vitro. Moreover, gastrin treatment in vitro promoted sphere formation from sorted Cck2r+Hdc- cells, and increased chromogranin A and phosphorylated- extracellular signal-regulated kinase expression in CCK2R-derived organoids. Gastrin activates extracellular signal-regulated kinase pathways in vivo and in vitro, and treatment with the Mitogen-activated protein kinase kinase 1 inhibitor U0126 blocked hypergastrinemia-mediated changes, including CCK2R-derived ECL cell hyperplasia in vivo as well as sphere formation and chromogranin A expression in vitro. We show here that hypergastrinemia induces ECL cell hyperplasia that is derived primarily from CCK2R+ progenitors in the corpus. Gastrin-dependent function of CCK2R+ progenitors is regulated by the extracellular signal-regulated kinase pathway. [Display omitted]
doi_str_mv 10.1016/j.jcmgh.2020.04.008
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7371950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2352345X20300527</els_id><sourcerecordid>2394878592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-9b49d4b36dfc21de073ef66dac7f7e2f92d523e9def6731ede1b30797246df453</originalsourceid><addsrcrecordid>eNp9UU1rGzEQFaWlDml-QSDsMVC80efKe0jALG4SYmgJDuQShCzNrmW8K1dam-TfV_5oSC89zTDz3psnPYTOCc4JJsXVMl-atlnkFFOcY55jPPqETigTdMi4eP78oR-gsxiXGGPCZSGx-IoGjDKGJSMn6OXubQ2h0bEProPW6WzyutadjdntfmaySTXNKlitYjZbBL9pFllVPdDH79mv4BvoXO_Dcb_dsR8fsrHp3Vb3znff0JdaryKcHespevoxmVV3w-nP2_tqPB0aQUU_LOe8tHzOClsbSiwka1AXhdVG1hJoXVIrKIPSpmlyDRbIPPkvJeWJwgU7RTcH3fVm3oI10PVBr9Q6uFaHN-W1U_9uOrdQjd8qySQpBU4Cl0eB4H9vIPaqddGkV-kO_CYqyko-kiNR0gRlB6gJPsYA9fsZgtUuG7VU-2zULhuFuUrZJNbFR4fvnL9JJMD1AQDpn7YOgorGQWfAugCmV9a7_x74A5g3obs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2394878592</pqid></control><display><type>article</type><title>Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK Activation</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Sheng, Weiwei ; Malagola, Ermanno ; Nienhüser, Henrik ; Zhang, Zhengyu ; Kim, Woosook ; Zamechek, Leah ; Sepulveda, Antonia ; Hata, Masahiro ; Hayakawa, Yoku ; Zhao, Chun-Mei ; Chen, Duan ; Wang, Timothy C.</creator><creatorcontrib>Sheng, Weiwei ; Malagola, Ermanno ; Nienhüser, Henrik ; Zhang, Zhengyu ; Kim, Woosook ; Zamechek, Leah ; Sepulveda, Antonia ; Hata, Masahiro ; Hayakawa, Yoku ; Zhao, Chun-Mei ; Chen, Duan ; Wang, Timothy C.</creatorcontrib><description>Enterochromaffin-like (ECL) cells in the stomach express gastrin/cholecystokinin 2 receptor CCK2R and are known to expand under hypergastrinemia, but whether this results from expansion of existing ECL cells or increased production from progenitors has not been clarified. We used mice with green fluorescent protein fluorescent reporter expression in ECL cells (histidine decarboxylase [Hdc]-green fluorescent protein), as well as Cck2r- and Hdc-driven Tamoxifen inducible recombinase Cre (Cck2r-CreERT2, Hdc-CreERT2) mice combined with Rosa26Sor-tdTomato (R26-tdTomato) mice, and studied their expression and cell fate in the gastric corpus by using models of hypergastrinemia (gastrin infusion, omeprazole treatment). Hdc-GFP marked the majority of ECL cells, located in the lower third of the gastric glands. Hypergastrinemia led to expansion of ECL cells that was not restricted to the gland base, and promoted cellular proliferation (Ki67) in the gastric isthmus but not in basal ECL cells. Cck2r-CreERT2 mice marked most ECL cells, as well as scattered cell types located higher up in the glands, whose number was increased during hypergastrinemia. Cck2r-CreERT2+ isthmus progenitors, but not Hdc+ mature ECL cells, were the source of ECL cell hyperplasia during hypergastrinemia and could grow as 3-dimensional spheroids in vitro. Moreover, gastrin treatment in vitro promoted sphere formation from sorted Cck2r+Hdc- cells, and increased chromogranin A and phosphorylated- extracellular signal-regulated kinase expression in CCK2R-derived organoids. Gastrin activates extracellular signal-regulated kinase pathways in vivo and in vitro, and treatment with the Mitogen-activated protein kinase kinase 1 inhibitor U0126 blocked hypergastrinemia-mediated changes, including CCK2R-derived ECL cell hyperplasia in vivo as well as sphere formation and chromogranin A expression in vitro. We show here that hypergastrinemia induces ECL cell hyperplasia that is derived primarily from CCK2R+ progenitors in the corpus. Gastrin-dependent function of CCK2R+ progenitors is regulated by the extracellular signal-regulated kinase pathway. [Display omitted]</description><identifier>ISSN: 2352-345X</identifier><identifier>EISSN: 2352-345X</identifier><identifier>DOI: 10.1016/j.jcmgh.2020.04.008</identifier><identifier>PMID: 32330731</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>CCK2R or Gastrin Receptor ; Cholecystokin-2 Receptor (CCK2R) ; Chromogranin A (CgA) ; Enterochromaffin-Like (ECL) Cells ; Gastrin ; Histidine Decarboxylase (Hdc) ; Original Research ; Progenitor Cell ; Proton Pump Inhibitors (PPI) ; Stem Cell Niche</subject><ispartof>Cellular and molecular gastroenterology and hepatology, 2020-01, Vol.10 (2), p.434-449.e1</ispartof><rights>2020 The Authors</rights><rights>Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>2020 The Authors 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-9b49d4b36dfc21de073ef66dac7f7e2f92d523e9def6731ede1b30797246df453</citedby><cites>FETCH-LOGICAL-c525t-9b49d4b36dfc21de073ef66dac7f7e2f92d523e9def6731ede1b30797246df453</cites><orcidid>0000-0001-5730-3019 ; 0000-0002-9124-9500</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371950/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371950/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32330731$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sheng, Weiwei</creatorcontrib><creatorcontrib>Malagola, Ermanno</creatorcontrib><creatorcontrib>Nienhüser, Henrik</creatorcontrib><creatorcontrib>Zhang, Zhengyu</creatorcontrib><creatorcontrib>Kim, Woosook</creatorcontrib><creatorcontrib>Zamechek, Leah</creatorcontrib><creatorcontrib>Sepulveda, Antonia</creatorcontrib><creatorcontrib>Hata, Masahiro</creatorcontrib><creatorcontrib>Hayakawa, Yoku</creatorcontrib><creatorcontrib>Zhao, Chun-Mei</creatorcontrib><creatorcontrib>Chen, Duan</creatorcontrib><creatorcontrib>Wang, Timothy C.</creatorcontrib><title>Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK Activation</title><title>Cellular and molecular gastroenterology and hepatology</title><addtitle>Cell Mol Gastroenterol Hepatol</addtitle><description>Enterochromaffin-like (ECL) cells in the stomach express gastrin/cholecystokinin 2 receptor CCK2R and are known to expand under hypergastrinemia, but whether this results from expansion of existing ECL cells or increased production from progenitors has not been clarified. We used mice with green fluorescent protein fluorescent reporter expression in ECL cells (histidine decarboxylase [Hdc]-green fluorescent protein), as well as Cck2r- and Hdc-driven Tamoxifen inducible recombinase Cre (Cck2r-CreERT2, Hdc-CreERT2) mice combined with Rosa26Sor-tdTomato (R26-tdTomato) mice, and studied their expression and cell fate in the gastric corpus by using models of hypergastrinemia (gastrin infusion, omeprazole treatment). Hdc-GFP marked the majority of ECL cells, located in the lower third of the gastric glands. Hypergastrinemia led to expansion of ECL cells that was not restricted to the gland base, and promoted cellular proliferation (Ki67) in the gastric isthmus but not in basal ECL cells. Cck2r-CreERT2 mice marked most ECL cells, as well as scattered cell types located higher up in the glands, whose number was increased during hypergastrinemia. Cck2r-CreERT2+ isthmus progenitors, but not Hdc+ mature ECL cells, were the source of ECL cell hyperplasia during hypergastrinemia and could grow as 3-dimensional spheroids in vitro. Moreover, gastrin treatment in vitro promoted sphere formation from sorted Cck2r+Hdc- cells, and increased chromogranin A and phosphorylated- extracellular signal-regulated kinase expression in CCK2R-derived organoids. Gastrin activates extracellular signal-regulated kinase pathways in vivo and in vitro, and treatment with the Mitogen-activated protein kinase kinase 1 inhibitor U0126 blocked hypergastrinemia-mediated changes, including CCK2R-derived ECL cell hyperplasia in vivo as well as sphere formation and chromogranin A expression in vitro. We show here that hypergastrinemia induces ECL cell hyperplasia that is derived primarily from CCK2R+ progenitors in the corpus. Gastrin-dependent function of CCK2R+ progenitors is regulated by the extracellular signal-regulated kinase pathway. [Display omitted]</description><subject>CCK2R or Gastrin Receptor</subject><subject>Cholecystokin-2 Receptor (CCK2R)</subject><subject>Chromogranin A (CgA)</subject><subject>Enterochromaffin-Like (ECL) Cells</subject><subject>Gastrin</subject><subject>Histidine Decarboxylase (Hdc)</subject><subject>Original Research</subject><subject>Progenitor Cell</subject><subject>Proton Pump Inhibitors (PPI)</subject><subject>Stem Cell Niche</subject><issn>2352-345X</issn><issn>2352-345X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9UU1rGzEQFaWlDml-QSDsMVC80efKe0jALG4SYmgJDuQShCzNrmW8K1dam-TfV_5oSC89zTDz3psnPYTOCc4JJsXVMl-atlnkFFOcY55jPPqETigTdMi4eP78oR-gsxiXGGPCZSGx-IoGjDKGJSMn6OXubQ2h0bEProPW6WzyutadjdntfmaySTXNKlitYjZbBL9pFllVPdDH79mv4BvoXO_Dcb_dsR8fsrHp3Vb3znff0JdaryKcHespevoxmVV3w-nP2_tqPB0aQUU_LOe8tHzOClsbSiwka1AXhdVG1hJoXVIrKIPSpmlyDRbIPPkvJeWJwgU7RTcH3fVm3oI10PVBr9Q6uFaHN-W1U_9uOrdQjd8qySQpBU4Cl0eB4H9vIPaqddGkV-kO_CYqyko-kiNR0gRlB6gJPsYA9fsZgtUuG7VU-2zULhuFuUrZJNbFR4fvnL9JJMD1AQDpn7YOgorGQWfAugCmV9a7_x74A5g3obs</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Sheng, Weiwei</creator><creator>Malagola, Ermanno</creator><creator>Nienhüser, Henrik</creator><creator>Zhang, Zhengyu</creator><creator>Kim, Woosook</creator><creator>Zamechek, Leah</creator><creator>Sepulveda, Antonia</creator><creator>Hata, Masahiro</creator><creator>Hayakawa, Yoku</creator><creator>Zhao, Chun-Mei</creator><creator>Chen, Duan</creator><creator>Wang, Timothy C.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5730-3019</orcidid><orcidid>https://orcid.org/0000-0002-9124-9500</orcidid></search><sort><creationdate>20200101</creationdate><title>Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK Activation</title><author>Sheng, Weiwei ; Malagola, Ermanno ; Nienhüser, Henrik ; Zhang, Zhengyu ; Kim, Woosook ; Zamechek, Leah ; Sepulveda, Antonia ; Hata, Masahiro ; Hayakawa, Yoku ; Zhao, Chun-Mei ; Chen, Duan ; Wang, Timothy C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-9b49d4b36dfc21de073ef66dac7f7e2f92d523e9def6731ede1b30797246df453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CCK2R or Gastrin Receptor</topic><topic>Cholecystokin-2 Receptor (CCK2R)</topic><topic>Chromogranin A (CgA)</topic><topic>Enterochromaffin-Like (ECL) Cells</topic><topic>Gastrin</topic><topic>Histidine Decarboxylase (Hdc)</topic><topic>Original Research</topic><topic>Progenitor Cell</topic><topic>Proton Pump Inhibitors (PPI)</topic><topic>Stem Cell Niche</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheng, Weiwei</creatorcontrib><creatorcontrib>Malagola, Ermanno</creatorcontrib><creatorcontrib>Nienhüser, Henrik</creatorcontrib><creatorcontrib>Zhang, Zhengyu</creatorcontrib><creatorcontrib>Kim, Woosook</creatorcontrib><creatorcontrib>Zamechek, Leah</creatorcontrib><creatorcontrib>Sepulveda, Antonia</creatorcontrib><creatorcontrib>Hata, Masahiro</creatorcontrib><creatorcontrib>Hayakawa, Yoku</creatorcontrib><creatorcontrib>Zhao, Chun-Mei</creatorcontrib><creatorcontrib>Chen, Duan</creatorcontrib><creatorcontrib>Wang, Timothy C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cellular and molecular gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheng, Weiwei</au><au>Malagola, Ermanno</au><au>Nienhüser, Henrik</au><au>Zhang, Zhengyu</au><au>Kim, Woosook</au><au>Zamechek, Leah</au><au>Sepulveda, Antonia</au><au>Hata, Masahiro</au><au>Hayakawa, Yoku</au><au>Zhao, Chun-Mei</au><au>Chen, Duan</au><au>Wang, Timothy C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK Activation</atitle><jtitle>Cellular and molecular gastroenterology and hepatology</jtitle><addtitle>Cell Mol Gastroenterol Hepatol</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>10</volume><issue>2</issue><spage>434</spage><epage>449.e1</epage><pages>434-449.e1</pages><issn>2352-345X</issn><eissn>2352-345X</eissn><abstract>Enterochromaffin-like (ECL) cells in the stomach express gastrin/cholecystokinin 2 receptor CCK2R and are known to expand under hypergastrinemia, but whether this results from expansion of existing ECL cells or increased production from progenitors has not been clarified. We used mice with green fluorescent protein fluorescent reporter expression in ECL cells (histidine decarboxylase [Hdc]-green fluorescent protein), as well as Cck2r- and Hdc-driven Tamoxifen inducible recombinase Cre (Cck2r-CreERT2, Hdc-CreERT2) mice combined with Rosa26Sor-tdTomato (R26-tdTomato) mice, and studied their expression and cell fate in the gastric corpus by using models of hypergastrinemia (gastrin infusion, omeprazole treatment). Hdc-GFP marked the majority of ECL cells, located in the lower third of the gastric glands. Hypergastrinemia led to expansion of ECL cells that was not restricted to the gland base, and promoted cellular proliferation (Ki67) in the gastric isthmus but not in basal ECL cells. Cck2r-CreERT2 mice marked most ECL cells, as well as scattered cell types located higher up in the glands, whose number was increased during hypergastrinemia. Cck2r-CreERT2+ isthmus progenitors, but not Hdc+ mature ECL cells, were the source of ECL cell hyperplasia during hypergastrinemia and could grow as 3-dimensional spheroids in vitro. Moreover, gastrin treatment in vitro promoted sphere formation from sorted Cck2r+Hdc- cells, and increased chromogranin A and phosphorylated- extracellular signal-regulated kinase expression in CCK2R-derived organoids. Gastrin activates extracellular signal-regulated kinase pathways in vivo and in vitro, and treatment with the Mitogen-activated protein kinase kinase 1 inhibitor U0126 blocked hypergastrinemia-mediated changes, including CCK2R-derived ECL cell hyperplasia in vivo as well as sphere formation and chromogranin A expression in vitro. We show here that hypergastrinemia induces ECL cell hyperplasia that is derived primarily from CCK2R+ progenitors in the corpus. Gastrin-dependent function of CCK2R+ progenitors is regulated by the extracellular signal-regulated kinase pathway. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32330731</pmid><doi>10.1016/j.jcmgh.2020.04.008</doi><orcidid>https://orcid.org/0000-0001-5730-3019</orcidid><orcidid>https://orcid.org/0000-0002-9124-9500</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2352-345X
ispartof Cellular and molecular gastroenterology and hepatology, 2020-01, Vol.10 (2), p.434-449.e1
issn 2352-345X
2352-345X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7371950
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects CCK2R or Gastrin Receptor
Cholecystokin-2 Receptor (CCK2R)
Chromogranin A (CgA)
Enterochromaffin-Like (ECL) Cells
Gastrin
Histidine Decarboxylase (Hdc)
Original Research
Progenitor Cell
Proton Pump Inhibitors (PPI)
Stem Cell Niche
title Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK Activation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T14%3A15%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypergastrinemia%20Expands%20Gastric%20ECL%20Cells%20Through%20CCK2R+%20Progenitor%20Cells%20via%20ERK%20Activation&rft.jtitle=Cellular%20and%20molecular%20gastroenterology%20and%20hepatology&rft.au=Sheng,%20Weiwei&rft.date=2020-01-01&rft.volume=10&rft.issue=2&rft.spage=434&rft.epage=449.e1&rft.pages=434-449.e1&rft.issn=2352-345X&rft.eissn=2352-345X&rft_id=info:doi/10.1016/j.jcmgh.2020.04.008&rft_dat=%3Cproquest_pubme%3E2394878592%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2394878592&rft_id=info:pmid/32330731&rft_els_id=S2352345X20300527&rfr_iscdi=true